Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
  • Financial Information
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Press Releases

Nov 03, 2026
Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences
Oct 22, 2026
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Oct 08, 2026
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
Oct 08, 2026
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
Sep 28, 2026
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
Sep 15, 2026
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
Aug 31, 2026
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
Aug 26, 2026
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Aug 20, 2026
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
Aug 06, 2026
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 29
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2026 Hyperfine, Inc. All rights reserved. Privacy Policy   Cookie Notice   Cookie Preferences